Prosecution Insights
Prosecution Insights
8 pending office actions • 5 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (38%) |
| Double-patenting + other | 1 (12%) |
| Multi-statute (no §101) | 4 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OTTON, ALICIA L | 1 | 65.0% | +9.2% |
| CHO, DAVID H | 1 | 37.5% | +73.5% |
| RODRIGUEZ-GARCIA, VALERIE | 1 | 68.8% | +31.9% |
| NGUYEN, JOHN P | 1 | 44.1% | +41.5% |
| KASSA, TIGABU | 1 | 36.5% | +28.2% |
| KOSTURKO, GEORGE W | 1 | 54.7% | +48.6% |
| GOTFREDSON, GAREN | 1 | 39.8% | +28.9% |
| KWON, JOHN SEUNGJAI | 1 | 45.1% | +20.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18283478 | ADENOSINE DERIVATIVE HAVING ANTAGONISTIC ACTION ON A2A AND A3 ADENOSINE RECEPTORS AND METHOD FOR PREPARING SAME | CHO, DAVID H | 80d overdue |
| 17802054 | PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND | GOTFREDSON, GAREN | 30d overdue |
| 18282182 | NOVEL SALTS OF HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR AND USES THEREOF | RODRIGUEZ-GARCIA, VALERIE | — |
| 18032749 | ORALLY DISINTEGRATING TABLET COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND AND PREPARATION METHOD THEREOF | KASSA, TIGABU | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18283478 | ADENOSINE DERIVATIVE HAVING ANTAGONISTIC ACTION ON A2A AND A3 ADENOSINE RECEPTORS AND METHOD FOR PREPARING SAME | CHO, DAVID H | 80d overdue |
| 17802054 | PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND | GOTFREDSON, GAREN | 30d overdue |
| 18269421 | PHARMACEUTICAL COMPOSITION COMPRISING TEGOPRAZAN AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | NGUYEN, JOHN P | 28d |
| 18282182 | NOVEL SALTS OF HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR AND USES THEREOF | RODRIGUEZ-GARCIA, VALERIE | — |
| 18032749 | ORALLY DISINTEGRATING TABLET COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND AND PREPARATION METHOD THEREOF | KASSA, TIGABU | — |
| 17918386 | PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND | KOSTURKO, GEORGE W | — |
| 17802078 | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | KWON, JOHN SEUNGJAI | — |
| Art Unit | Apps |
|---|---|
| 1619 | 3 |
| 1621 | 2 |
| 1699 | 1 |
| 1693 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19444665 | NOVEL PREPARATION CONTAINING BENZIMIDAZOLE DERIVATIVE | OTTON, ALICIA L | 1699 | §102§103DPOther | Non-Final OA | — | Pending | Jan 09, 2026 |
| 18283478 | ADENOSINE DERIVATIVE HAVING ANTAGONISTIC ACTION ON A2A AND A3 ADENOSINE RECEPTORS AND METHOD FOR PREPARING SAME | CHO, DAVID H | 1693 | §103§112 | Non-Final OA | 80d overdue | Pending | Sep 22, 2023 |
| 18282182 | NOVEL SALTS OF HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR AND USES THEREOF | RODRIGUEZ-GARCIA, VALERIE | 1621 | §102§103 | Non-Final OA | — | Pending | Sep 14, 2023 |
| 18269421 | PHARMACEUTICAL COMPOSITION COMPRISING TEGOPRAZAN AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS | NGUYEN, JOHN P | 1619 | §103 | Non-Final OA | 28d | Pending | Jun 23, 2023 |
| 18032749 | ORALLY DISINTEGRATING TABLET COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND AND PREPARATION METHOD THEREOF | KASSA, TIGABU | 1619 | §103§112 | Final Rejection | — | Pending | Apr 19, 2023 |
| 17918386 | PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND | KOSTURKO, GEORGE W | 1621 | §103 | Final Rejection | — | Pending | Mar 27, 2023 |
| 17802054 | PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND | GOTFREDSON, GAREN | 1619 | §103§112 | Final Rejection | 30d overdue | Pending | Aug 24, 2022 |
| 17802078 | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | KWON, JOHN SEUNGJAI | 1615 | §103 | Non-Final OA | — | Pending | Aug 24, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial